1-3 of 3
Gabriel M. Cohn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cross Talk between Ikaros and RUNX1 in Myeloid Leukemia

Jessica L. Heath, MD, Jamie L. Deutsch, Gabriel M. Cohn, Joshua T. Rose, Gary S. Stein, PhD, Sayyed K. Zaidi, PhD, Seth E. Frietze, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3789.
https://doi.org/10.1182/blood.V130.Suppl_1.3789.3789
Published: 2017
Journal Articles

Report on the Safety of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease and the Transition From Clinic to Home Infusions During Treatment Protocol HGT-GCB-058

Gregory M Pastores, Barry E Rosenbloom, MD, Neal J Weinreb, Ozlem Goker-Alpan, Rebecca Mardach, Mark Lipson, Jennifer Ibrahim, Gabriel M Cohn, David Zahrieh, Pramod K Mistry
Journal: Blood
Blood (2011) 118 (21): 1101.
https://doi.org/10.1182/blood.V118.21.1101.1101
Published: 2011
Journal Articles

Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience

Clinical Trials & Observations
Ari Zimran, Gheona Altarescu, Mici Philips, Drorit Attias, Marina Jmoudiak, Maher Deeb, Nan Wang, Kiran Bhirangi, Gabriel M. Cohn, Deborah Elstein
Journal: Blood
Blood (2010) 115 (23): 4651–4656.
https://doi.org/10.1182/blood-2010-02-268649
Published: 2010